FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Tolmar Naftifine Hydrochloride Gel Recall

Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt

Tolmar, Inc. · Fort Collins, CO

Risk level
Class II
Reported by FDA
Aug 10, 2022
Recall ID
D-1300-2022
Check your lot numberHow we source this data

Summary

Tolmar recalled Naftifine Hydrochloride Gel starting Jul 11, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1300-2022 on Aug 10, 2022. Reason: Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time. Status: Terminated.

Why it was recalled

Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time

Product description

Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48), b) Net Wt. 40g tube (NDC 0115-1510-63), c) Net Wt. 60g tube (NDC 0115-1510-58), Rx only, Manufactured by: Tolmar, Inc., Fort Collins, CO, 80526, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807

Lot numbers, UPCs & expiration codes

Lot #: a) 12070A, Exp 5/2023; 11801A, Exp 9/2022; b) 12386A, Exp 8/2023; 11800A, Exp 9/2022; c) 11940A, Exp 12/2022

Where it was sold

distributed to 1 consignee in KY.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1300-2022
Classification
Class II
Status
Terminated
Recall initiated
Jul 11, 2022
FDA report date
Aug 10, 2022
Quantity
1271 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Tolmar, Inc.

Original FDA data

Every field from FDA enforcement report D-1300-2022, exactly as published.

Show all FDA fields
City
Fort Collins
State
CO
Status
Terminated
Country
United States
Event ID
90580
Address
701 Centre Ave
Code information
Lot #: a) 12070A, Exp 5/2023; 11801A, Exp 9/2022; b) 12386A, Exp 8/2023; 11800A, Exp 9/2022; c) 11940A, Exp 12/2022
Postal code
80526-1843
Report date
Aug 10, 2022
Product type
Drugs
Recall number
D-1300-2022
Classification
Class II
Recalling firm
Tolmar, Inc.
Product quantity
1271 tubes
Termination date
Jun 22, 2023
Reason for recall
Failed Impurities/ degradation specifications: Out-of-Specification test results obtained for Unspecified Impurity Relative Retention Time
Voluntary / mandated
Voluntary: Firm initiated
Product description
Naftifine Hydrochloride Gel, USP 1%, packaged in cartons with: a) Net Wt. 90g tube (NDC 0115-1510-48), b) Net Wt. 40g tube (NDC 0115-1510-63), c) Net Wt. 60g tube (NDC 0115-1510-58), Rx only, Manufactured by: Tolmar, Inc., Fort Collins, CO, 80526, Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807
Distribution pattern
distributed to 1 consignee in KY.
Recall initiation date
Jul 11, 2022
Initial firm notification
Letter
Center classification date
Aug 1, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1300-2022, published Aug 10, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls